CLOV vs MOH

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 22, 2026

CLOV

44.5
AI Score
VS
CLOV Wins

MOH

24.9
AI Score

Investment Advisor Scores

CLOV

45score
Recommendation
HOLD

MOH

25score
Recommendation
STRONG SELL

AI Analyst Insights

Detailed Metrics Comparison

Metric CLOV MOH Winner
Forward P/E 37.7358 18.9036 MOH
PEG Ratio 0 0.887 Tie
Revenue Growth 55.6% -5.7% CLOV
Earnings Growth 0.0% -75.3% CLOV
Tradestie Score 44.5/100 24.9/100 CLOV
Profit Margin -0.7% -0.0% MOH
Beta 1.00 1.00 Tie
AI Recommendation HOLD STRONG SELL CLOV

Relative Price Performance (Last 90 Days)

CLOV 1M: +3.2% · 3M: +9.1% MOH 1M: +13.9% · 3M: +9.2%

Current Technical Phase

CLOV

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (1.2% over 20 days), RSI 54

RSI (14): 54.3 · Price: $4.72

MOH

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 62

RSI (14): 62.0 · Price: $215.65

Fundamentals Snapshot

Metric CLOV MOH
Market Cap — —
Forward P/E 31.5 25.3
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.6% -0.1%
Gross Margin 0.2% 0.1%
Operating Margin 0.0% 0.0%
EPS -0.05 -0.73
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, CLOV is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.